13.05.2016 08:45:01

DGAP-News: H&R Aktiengesellschaft

DGAP-News: H&R Aktiengesellschaft confirms good figures for First Quarter 2016

DGAP-News: H&R Aktiengesellschaft / Key word(s): Quarter Results/Quarterly / Interim Statement H&R Aktiengesellschaft confirms good figures for First Quarter 2016

13.05.2016 / 08:45 The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Press release

H&R AG confirms good preliminary figures for the first quarter of 2016

- EBITDA improved by some 76%



- Positive development of earnings in all three segments

- Forecast confirmed

Salzbergen (Germany), 13th May 2016. H&R AG has confirmed good preliminary figures for the early part of 2016: In the first quarter, the company achieved a significantly improved operating result (EBITDA) of EUR27.2 million (corresponding period of previous year: EUR15.5 million). The preceding quarter likewise resulted in positive figures on all earnings levels. As in previous quarters, sales revenues in this three-month period, amounting to EUR228.0 million, were influenced by raw material prices and therefore below the comparative previous level (approx.13.3% down; Q1 2015: EUR263.0 million).

Overview of the main figures:



in EUR m Q1/2016 Q1/2015 Diff. in % Sales revenues 228.0 263.0 -13.3 Operating result (EBITDA)) 27.2 15.5 75.5 EBIT 19.5 8.1 >100.0 EBT 16.7 5.0 >100.0 Income after taxes, 13.5 4.8 >100.0 attributable to H&R AG shareholders Consolidated earnings per 0.38 0.13 >100.0 share (EUR) Operating cash flow 24.4 -3.0 n.a. Free cash flow 15.6 -8.8 n.a. 31.3.2016 31.12.2015 Diff. in % Balance sheet total 635.7 628.8 1.1 Group equity 293.4 287.1 2.2 Equity capital ratio (%) 46.1 45.7 0.4*



* Shown in percentage points.

The ChemPharm Refining segment once again made the main contribution to improved results, with EBITDA of EUR20.9 million (Q1-2015: EUR9.8 million), despite a 15.1% drop in sales revenues to EUR142.8 million (Q1-2015: EUR168.2 million). These sales revenues were achieved thanks to still comparatively low raw material prices, while margins for our products remained stable in the first quarter of 2016, with good demand and steady product prices. The international activities of the ChemPharm sales segment achieved, with an EBITDA of EUR7.9 million (Q1-2015: EUR6.1 million), a 29.5% improvement in results. Sales revenues at the beginning of the year remained, at EUR77.5 million, a moderate 5.6% below those of the same period of the previous year quarter (Q1-2015: EUR82.1 million). The Plastics segment posted a positive result, but remained below the previous year's figure with respect to EBITDA (Q1-2016: EUR0.2 million; Q1-2015: EUR0.3 million) and also sales (Q1-2016: EUR13.5 million; Q1-2015: EUR15.3 million).

In view of the current discussions concerning the production levels of the crude oil exporting countries and the related sensitivity of market and product prices as well as the associated social and geopolitical challenges, for the time being we believe it appropriate to confirm our current forecast for 2016: The company expects results corresponding to the good level of the previous year.

The company refers, with respect to detailed statements on business development and the state of earnings, to the interim statement on the first quarter of 2016, which is made available via the "Download" section of the H&R AG website at www.hur.com.

Contact information: H&R AG, Investor Relations/Communications, Ties Kaiser Neuenkirchener Strasse 8, 48499 Salzbergen Tel.: +49 40 43218-321, Fax: +49 40 43218-390 E-mail: Ties.Kaiser@hur.com www.hur.com

H&R AG: H&R AG is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil- based chemical and pharmaceutical specialty products and produces high- precision plastic parts.

Forward-looking statements and forecasts: This press release contains forward-looking statements. These statements are based on current estimates and forecasts made by the Executive Board and the information available to the Board at this time. Forward-looking statements should not be interpreted as guarantees that the projected future developments and results will materialize. Future developments and results are dependent on a range of factors. They comprise various risks and imponderables and rest on assumptions which may prove incorrect. We do not accept any obligation to update the forward-looking statements made in this press release.

---------------------------------------------------------------------------

13.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English Company: H&R Aktiengesellschaft Neuenkirchener Str. 8 48499 Salzbergen Germany Phone: +49 (0)40 43 218 321 Fax: +49 (0)40 43 218 390 E-mail: investor.relations@hur.com Internet: www.hur.com ISIN: DE0007757007 WKN: 775700 Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart End of News DGAP News Service ---------------------------------------------------------------------------

463419 13.05.2016

Nachrichten zu H&R GmbH & Co. KGaAmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu H&R GmbH & Co. KGaAmehr Analysen

23.07.24 H&R Halten DZ BANK
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!